New Mount Sinai center focuses on advancing personalized treatments for peanut allergy

New Mount Sinai center focuses on advancing personalized treatments for peanut allergy

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a five-year, $7.2 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to establish a new Asthma and Allergic Diseases Cooperative Research Center focused on advancing personalized treatment strategies for peanut allergy.